Analogue-based drug discovery III /

Analogue-based drug discovery III /

"Most drugs are analogue drugs. There are no general rules how a new drug can be discovered, nevertheless, there are some observations which help to find a new drug, and also an individual story of a drug discovery can initiate and help new discoveries. Volume III is a continuation of the succe...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Άλλοι συγγραφείς: Fischer, János (Επιμελητής έκδοσης), Ganellin, C. R. (C. Robin) (Επιμελητής έκδοσης), Rotella, David P. (Επιμελητής έκδοσης)
Μορφή: Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Weinheim : Wiley-VCH, [2013]
Θέματα:
Drug development.
MEDICAL > Drug Guides.
MEDICAL > Nursing > Pharmacology.
MEDICAL > Pharmacology.
MEDICAL > Pharmacy.
Electronic books.
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 05273nam a2200733 4500
001 ocn826637765
003 OCoLC
005 20170124070742.4
006 m o d
007 cr cnu|||unuuu
008 130204t20132013gw ac ob 001 0 eng d
040 |a DG1  |b eng  |e rda  |e pn  |c DG1  |d EBLCP  |d N$T  |d MHW  |d YDXCP  |d COO  |d IDEBK  |d E7B  |d NOC  |d OCLCF  |d IUL  |d SCB  |d OCLCQ  |d CDX  |d NKT  |d OCLCQ  |d GrThAP 
019 |a 828869678  |a 828896125  |a 961601655  |a 962705463 
020 |a 9783527651085  |q (electronic bk.) 
020 |a 352765108X  |q (electronic bk.) 
020 |a 9783527651115  |q (electronic bk.) 
020 |a 352765111X  |q (electronic bk.) 
020 |a 9781299241206  |q (MyiLibrary) 
020 |a 1299241204  |q (MyiLibrary) 
020 |z 9783527330737 
020 |z 3527330739 
029 1 |a AU@  |b 000050562533 
029 1 |a AU@  |b 000053030546 
029 1 |a DKDLA  |b 820120-katalog:000655918 
029 1 |a NLGGC  |b 382514440 
029 1 |a NZ1  |b 15340091 
029 1 |a DEBBG  |b BV043395341 
035 |a (OCoLC)826637765  |z (OCoLC)828869678  |z (OCoLC)828896125  |z (OCoLC)961601655  |z (OCoLC)962705463 
037 |a 455370  |b MIL 
050 4 |a RM301.25  |b .A53 2013 
072 7 |a MED  |x 023000  |2 bisacsh 
072 7 |a MED  |x 058170  |2 bisacsh 
072 7 |a MED  |x 071000  |2 bisacsh 
072 7 |a MED  |x 072000  |2 bisacsh 
072 7 |a HEA  |2 eflch 
082 0 4 |a 615.1/9  |2 23 
049 |a MAIN 
245 0 0 |a Analogue-based drug discovery III /  |c edited by János Fischer, C. Robin Ganellin, David P. Rotella. 
246 3 |a Analogue-based drug discovery 3 
246 3 |a Analog-based drug discovery III 
264 1 |a Weinheim :  |b Wiley-VCH,  |c [2013] 
264 4 |c ©2013 
300 |a 1 online resource (xviii, 385 pages) :  |b illustrations, portraits 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
588 0 |a Online resource; title page from PDF title page (viewed June 30, 2014). 
505 0 0 |t General Aspects. Pioneer and Analogue Drugs /  |r Janos Fischer, C Robin Ganellin, David P Rotella --  |t Competition in the Pharmaceutical Drug Development /  |r Christian Tyrchan, Fabrizio Giordanetto --  |t Metabolic Stability and Analogue-Based Drug Discovery /  |r Amit S Kalgutkar, Antonia F Stepan --  |t Use of Macrocycles in Drug Design Exemplified with Ulimorelin, a Potential Ghrelin Agonist for Gastrointestinal Motility Disorders /  |r Mark L Peterson, Hamid Hoveyda, Graeme Fraser, Eric Marsault, Rene Gagnon --  |t Drug Classes. The Discovery of Anticancer Drugs Targeting Epigenetic Enzymes /  |r A Ganesan --  |t Thienopyridyl and Direct-Acting P2Y Receptor Antagonist Antiplatelet Drugs /  |r Joseph A Jakubowski, Atsuhiro Sugidachi --  |t Selective Estrogen Receptor Modulators /  |r Amarjit Luniwal, Rachael Jetson, Paul Erhardt --  |t Discovery of Nonpeptide Vasopressin V2 Receptor Antagonists /  |r Kazumi Kondo, Hidenori Ogawa --  |t The Development of Cysteinyl Leukotriene Receptor Antagonists /  |r Peter R Bernstein --  |t Case Studies. The Discovery of Dabigatran Etexilate /  |r Norbert Hauel, Andreas Clemens, Herbert Nar, Henning Priepke, Joanne van Ryn, Wolfgang Wienen --  |t The Discovery of Citalopram and Its Refinement to Escitalopram /  |r Klaus P Bogeso, Connie Sanchez --  |t Tapentadol : From Morphine and Tramadol to the Discovery of Tapentadol /  |r Helmut Buschmann --  |t Novel Taxanes: Cabazitaxel Case Study /  |r Herve Bouchard, Dorothee Semiond, Marie-Laure Risse, Patricia Vrignaud --  |t Discovery of Boceprevir and Narlaprevir: A Case Study for Role of Structure-Based Drug Design /  |r Srikanth Venkatraman, Andrew Prongay, George F Njoroge --  |t A New-Generation Uric Acid Production Inhibitor: Febuxostat /  |r Ken Okamoto, Shiro Kondo, Takeshi Nishino. 
504 |a Includes bibliographical references and index. 
520 |a "Most drugs are analogue drugs. There are no general rules how a new drug can be discovered, nevertheless, there are some observations which help to find a new drug, and also an individual story of a drug discovery can initiate and help new discoveries. Volume III is a continuation of the successful book series with new examples of established and recently introduced drugs. The major part of the book is written by key inventors either as a case study or a study of an analogue class. With its wide range across a variety of therapeutic fields and chemical classes, this is of interest to virtually every researcher in drug discovery and pharmaceutical chemistry, and--together with the previous volumes--constitutes the first systematic approach to drug analogue development"--Publisher's website. 
650 0 |a Drug development. 
650 7 |a MEDICAL  |x Drug Guides.  |2 bisacsh 
650 7 |a MEDICAL  |x Nursing  |x Pharmacology.  |2 bisacsh 
650 7 |a MEDICAL  |x Pharmacology.  |2 bisacsh 
650 7 |a MEDICAL  |x Pharmacy.  |2 bisacsh 
650 7 |a Drug development.  |2 fast  |0 (OCoLC)fst00898670 
655 4 |a Electronic books. 
655 7 |a Electronic books.  |2 local 
700 1 |a Fischer, János,  |e editor. 
700 1 |a Ganellin, C. R.  |q (C. Robin),  |e editor. 
700 1 |a Rotella, David P.,  |e editor. 
776 0 8 |i Print version:  |t Analogue-based drug discovery III.  |d Weinheim : Wiley-VCH, [2013]  |z 9783527330737  |w (OCoLC)825555931 
856 4 0 |u https://doi.org/10.1002/9783527651085  |z Full Text via HEAL-Link 
994 |a 92  |b DG1 

Παρόμοια τεκμήρια